Transforming Growth Factor-β3–Mediated Suppression of SOX2 and OCT4 Drives a Predominantly Noncanonical Profile of Epithelial-Mesenchymal Transition during Palatal Fusion
Transforming Growth Factor-β3–Mediated Suppression of SOX2 and OCT4 Drives a Predominantly Noncanonical Profile of Epithelial-Mesenchymal Transition during Palatal Fusion. // The American Journal of Pathology. – URL: https://www.sciencedirect.com/science/article/pii/S0002944026002622?dgcid=rss_sd_all
Transforming Growth Factor-β3–Mediated Suppression of SOX2 and OCT4 Drives a Predominantly Noncanonical Profile of Epithelial-Mesenchymal Transition during Palatal Fusion. The American Journal of Pathology. https://www.sciencedirect.com/science/article/pii/S0002944026002622?dgcid=rss_sd_all
“Transforming Growth Factor-β3–Mediated Suppression of SOX2 and OCT4 Drives a Predominantly Noncanonical Profile of Epithelial-Mesenchymal Transition during Palatal Fusion.” The American Journal of Pathology.
@article{article95292,
title = {Transforming Growth Factor-β3–Mediated Suppression of SOX2 and OCT4 Drives a Predominantly Noncanonical Profile of Epithelial-Mesenchymal Transition during Palatal Fusion},
journal = {The American Journal of Pathology},
url = {https://www.sciencedirect.com/science/article/pii/S0002944026002622?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....